NCT07752797 Assessment of Ultrasound Findings, Nerve Test Results, and Hand Function in Patients With Carpal Tunnel Syndrome
| NCT ID | NCT07752797 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2026-06-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Carpal tunnel syndrome is one of the most common conditions caused by compression of a nerve at the wrist. It can lead to numbness, tingling, pain, weakness, and difficulty performing daily activities. Although nerve conduction studies are widely used to confirm the diagnosis and assess disease severity, ultrasonography has become an increasingly important, non-invasive diagnostic tool. However, the relationship between ultrasound findings, nerve conduction study results, hand function, and symptom severity has not been fully clarified. The purpose of this study is to investigate the relationship between the clinical severity of carpal tunnel syndrome and ultrasonographic, electrophysiological, and functional parameters. Participants with carpal tunnel syndrome will undergo ultrasonographic measurement of the median nerve, nerve conduction studies, hand grip strength assessment, pressure pain threshold measurement, and completion of the Boston Carpal Tunnel Questionnaire. The investigators hypothesize that greater clinical severity will be associated with larger median nerve cross-sectional area, more severe electrophysiological abnormalities, reduced hand grip strength, lower pressure pain threshold, and poorer functional status. The findings of this study may improve the understanding of the relationship between structural, electrophysiological, and functional changes in carpal tunnel syndrome and contribute to clinical evaluation and patient management.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Clinical findings consistent with carpal tunnel syndrome * Carpal tunnel syndrome confirmed by electroneuromyography * Ability to understand and complete the study assessments * Provision of written informed consent Exclusion Criteria: * Previous carpal tunnel release surgery * History of fracture, major trauma, or surgery involving the assessed wrist or hand * Cervical radiculopathy, brachial plexopathy, or other peripheral neuropathy affecting the upper extremity * Polyneuropathy * Inflammatory rheumatic disease or active infection involving the assessed upper extremity * Severe neurological or musculoskeletal disorder that may affect hand function * Inability to complete ultrasonographic, electrophysiological, functional, or questionnaire assessments
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07752797 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07752797 currently recruiting?
Yes, NCT07752797 is actively recruiting participants. Contact the research team at haticezehraferhatlar@gmail.com for enrollment information.
Where is the NCT07752797 trial being conducted?
This trial is being conducted at Küçükçekmece, Turkey (Türkiye).
Who is sponsoring the NCT07752797 clinical trial?
NCT07752797 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital. The trial plans to enroll 90 participants.